Biohaven Ltd share price logo

Biohaven Ltd Share Price

NYSE: BHVN

Mid Cap

$15.89

-0.32

(-1.97%)

Live

as on

Biohaven Ltd Stock Performance

as on September 4, 2025 at 8:36 pm IST

  • Day's Low

    Day's High

    $15.72
    $16.27
    downward going graph

    1.07%

    Downside

    2.39%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $12.79
    $55.7
    downward going graph

    19.51%

    Downside

    250.53%

    Upside

    downward going graph

Biohaven Ltd share price movements today

Previous Close
$16.21
Open
$16.06
Volume
391.7K
Day's Low - High
$15.72 - $16.27
52 Week Low - High
$12.79 - $55.7

Biohaven Ltd Historical Returns

1 Month Return
+ 10.2 %
3 Month Return
0 %
1 Year Return
-57.17 %
3 Year Return
-89.17 %
5 Year Return
-74 %

Biohaven Ltd Stock Fundamentals & Key Indicators

Check Biohaven Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.7B

EPS (TTM)

-6.2755

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-928.7M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

292509600.00%

Biohaven Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biohaven Ltd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.7B-74%NA0.00%
BUY$58.6B264.27%-505.15-12.96%
NA$39.4BNANA-3.89%
BUY$101.7BNA28.2531.86%
BUY$59.8B-2.85%14.2131.37%

Stock Returns calculator for Biohaven Ltd Stock including INR - Dollar returns

The Biohaven Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Biohaven Ltd investment value today

Current value as on today

₹46,996

Returns

₹53,004

(-53%)

Returns from Biohaven Ltd Stock

₹58,018 (-58.02%)

Dollar Returns*

₹5,014 (+5.01%)

Analyst Recommendation on Biohaven Ltd Stock

Based on 17 analysts

BUY

94.12%

Buy

5.88%

Hold

0.00%

Sell

Based on 17 analysts, 94.12% of analysts recommend a 'BUY' rating for Biohaven Ltd. Average target price of $48.88

Biohaven Ltd Share Price Target

Get share price movements and forecasts by analysts on Biohaven Ltd.

What analysts predicted

67.49%UPSIDE

Target Price

$48.88

Current Price

$15.89

Analyzed by

17 Analysts

Target

$48.88

Biohaven Ltd target price $48.88, a slight upside of 67.49% compared to current price of $15.89. According to 17 analysts rating.

Biohaven Ltd Stock's Interest Amongst Investors

Investment in Biohaven Ltd Shares on INDmoney has dropped by -52.17% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-52.17% versus previous 30 day period

Search interest for Biohaven Ltd Stock has increased by 3% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:3% versus previous 30 day period

Biohaven Ltd Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
-
-
-
3
-
-
Gross Profit
0
0
0
0
0
0
-1
1
-1
-
Operating Income
-77
-94
-110
-153
-183
-333
-178
-189
-221
-211
EBITDA
-76
-92
-109
-151
-181
-331
-176
-176
-221
-211
Interest Expense
8
-
-
-
-
-
-
-
-
-
Depreciation
1
1
1
1
1
1
1
2
2
1
Income Before Tax
-69
-88
-105
-145
-178
-319
-160
-186
-221
-197
Income Tax Expense
0
2
-3
-1
0
0
0
0
0
0
Net Income
-70
-90
-102
-144
-179
-319
-160
-186
-221
-198
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-4870.78%
0.00%
0.00%

Biohaven Ltd Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
462
-
-
-
Gross Profit
0
370
-1
-3
-3
Operating Income
-114
-218
-567
-436
-885
EBITDA
-114
-217
-566
-429
-841
Interest Expense
-
41
1
-
-
Depreciation
0
1
1
6
7
Income Before Tax
-118
-212
-569
-409
-845
Income Tax Expense
0
1
0
-1
0
Net Income
-118
-213
-570
-408
-846
Net Profit Margin
0.00%
-46.23%
0.00%
0.00%
0.00%

Biohaven Ltd Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-90
-102
-144
-179
-319
-160
-186
-221
-198
Operating Cash Flow
-44
-94
-114
-102
-167
-141
-170
-165
-167
Investing Cash Flow
76
58
-3
34
-97
-93
-87
164
-15
Financing Cash Flow
-20
-39
245
3
321
80
272
0
249
Change in Cash
11
-75
126
-65
55
-154
14
0
66

Biohaven Ltd Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-240
-528
-118
-213
-570
-408
-846
Operating Cash Flow
-197
-377
-75
-145
-297
-331
-582
Investing Cash Flow
-10
-3
-2
0
-304
129
-244
Financing Cash Flow
340
434
152
138
767
211
677
Change in Cash
132
53
82
-6
165
9
-149

Global Institutional Holdings in Biohaven Ltd

Funds
Holdings
Vanguard Group Inc
8.25%
BlackRock Inc
7.33%
Stifel Financial Corp
6.47%
HHG PLC
6.3%
Suvretta Capital Management, LLC
5.5%

Insights on Biohaven Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, BHVN stock has moved up by 4.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 78.4% return, outperforming this stock by 135.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 101.7% return, outperforming this stock by 190.9%

About Biohaven Ltd

Biohaven Ltd. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments in key therapeutic areas, including immunology, neuroscience, and oncology. It is advancing its portfolio of therapeutics, leveraging its drug development experience and multiple proprietary drug development platforms. Its clinical and preclinical programs include Kv7 ion channel modulation for epilepsy and mood disorders; extracellular protein degradation for immunological diseases; TRPM3 antagonism for migraine and neuropathic pain; TYK2/JAK1 inhibition for neuroinflammatory disorders; glutamate modulation for obsessive-compulsive disorder (OCD) and spinocerebellar ataxia (SCA); myostatin inhibition for neuromuscular and metabolic diseases, including spinal muscular atrophy (SMA) and obesity; antibody recruiting bispecific molecules; and antibody drug conjugates for cancer. Its advanced product candidate from its glutamate receptor antagonist platform is troriluzole.
OrganisationBiohaven Ltd
Headquarters215 Church Street, New Haven, CT, United States, 06510
IndustryHealth Technology
CEODr. Vladimir Coric M.D.
E-voting on sharesClick here to vote

Key Management of Biohaven Ltd

Name

Title

Ms. Deb Young

Senior Director of Regulatory Affairs & Operations

Mr. Clifford Bechtold M.S.

President, GM of Biohaven Ireland & Chief Compliance Officer

Mr. John Tilton

Chief Commercial Officer of Rare Diseases

Dr. Vladimir Coric M.D.

Chairman & CEO

Dr. Bruce D. Car DACVP, Ph.D.

Chief Scientific Officer

Mr. George C. Clark CPA

VP & Chief Accounting Officer

Ms. Jennifer Porcelli

Vice President of Investor Relations

Mr. Warren Volles J.D.

General Counsel & Chief Legal Officer

Mr. Matthew Buten

Chief Financial Officer

Ms. Kimberly Gentile

Senior Vice President of Clinical Operations

FAQs

What is Biohaven Ltd share price today?

Biohaven Ltd share price today is $15.89 as on . Biohaven Ltd share today touched a day high of $16.27 and a low of $15.72.

What is the 52 week high and 52 week low for Biohaven Ltd share?

Biohaven Ltd share touched a 52 week high of $55.7 on and a 52 week low of $12.79 on . Biohaven Ltd stock price today i.e. is trending at $15.89,which is 71.47% down from its 52 week high and 24.24% up from its 52 week low.

What is Biohaven Ltd's market capitalisation today?

Biohaven Ltd market capitalisation is $0.00T as on .

How to invest in Biohaven Ltd Stock (BHVN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Biohaven Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biohaven Ltd Shares that will get you 0.0944 shares as per Biohaven Ltd share price of $15.89 per share as on September 4, 2025 at 8:36 pm IST.

What is the minimum amount required to buy Biohaven Ltd Stock (BHVN) from India?

Indian investors can start investing in Biohaven Ltd (BHVN) shares with as little as ₹88.115 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.15 in Biohaven Ltd stock (as per the Rupee-Dollar exchange rate as on ). Based on Biohaven Ltd share’s latest price of $15.89 as on September 4, 2025 at 8:36 pm IST, you will get 0.6293 shares of Biohaven Ltd. Learn more about fractional shares .

What are the returns that Biohaven Ltd has given to Indian investors in the last 5 years?

Biohaven Ltd stock has given -74% share price returns and 20.11% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?